Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome, Bacterial | 22 | 2026 | 139 | 4.400 |
Why?
|
| Escherichia coli Infections | 10 | 2026 | 45 | 3.340 |
Why?
|
| Escherichia coli O157 | 6 | 2022 | 17 | 2.440 |
Why?
|
| Shiga-Toxigenic Escherichia coli | 4 | 2026 | 7 | 1.940 |
Why?
|
| Virulence Factors | 6 | 2026 | 125 | 1.850 |
Why?
|
| Phylogeny | 16 | 2026 | 769 | 1.550 |
Why?
|
| Plasmids | 8 | 2022 | 244 | 1.310 |
Why?
|
| Yersinia pestis | 8 | 2012 | 35 | 1.290 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2019 | 90 | 0.980 |
Why?
|
| Disease Outbreaks | 4 | 2015 | 175 | 0.910 |
Why?
|
| Plague | 7 | 2012 | 25 | 0.900 |
Why?
|
| Bacteriophages | 3 | 2022 | 44 | 0.890 |
Why?
|
| Hemolytic-Uremic Syndrome | 2 | 2022 | 4 | 0.860 |
Why?
|
| Sequence Analysis, DNA | 11 | 2017 | 515 | 0.830 |
Why?
|
| Food Microbiology | 3 | 2019 | 39 | 0.810 |
Why?
|
| Laboratory Infection | 1 | 2022 | 2 | 0.760 |
Why?
|
| Anti-Bacterial Agents | 5 | 2022 | 432 | 0.750 |
Why?
|
| Genetic Variation | 6 | 2016 | 430 | 0.700 |
Why?
|
| Cholera | 4 | 2025 | 74 | 0.680 |
Why?
|
| Escherichia coli Proteins | 4 | 2026 | 133 | 0.670 |
Why?
|
| Virulence | 8 | 2026 | 246 | 0.660 |
Why?
|
| DNA, Bacterial | 8 | 2018 | 206 | 0.660 |
Why?
|
| Colistin | 2 | 2022 | 3 | 0.660 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2022 | 36 | 0.620 |
Why?
|
| Cheese | 1 | 2019 | 4 | 0.610 |
Why?
|
| Shigella sonnei | 1 | 2018 | 5 | 0.580 |
Why?
|
| Vibrio cholerae O1 | 2 | 2016 | 11 | 0.560 |
Why?
|
| Escherichia coli | 3 | 2022 | 460 | 0.560 |
Why?
|
| Reperfusion Injury | 4 | 1997 | 58 | 0.470 |
Why?
|
| Bacterial Proteins | 6 | 2025 | 595 | 0.440 |
Why?
|
| Enterohemorrhagic Escherichia coli | 1 | 2014 | 2 | 0.440 |
Why?
|
| Foodborne Diseases | 1 | 2014 | 23 | 0.430 |
Why?
|
| Endemic Diseases | 2 | 2016 | 23 | 0.430 |
Why?
|
| Molecular Sequence Data | 10 | 2015 | 1542 | 0.420 |
Why?
|
| Genomics | 3 | 2014 | 293 | 0.420 |
Why?
|
| DNA Transposable Elements | 2 | 2025 | 55 | 0.420 |
Why?
|
| Lung | 4 | 1997 | 492 | 0.390 |
Why?
|
| Gene Expression Regulation, Bacterial | 4 | 2025 | 171 | 0.380 |
Why?
|
| Thioredoxins | 2 | 2025 | 41 | 0.370 |
Why?
|
| Acinetobacter baumannii | 2 | 2025 | 40 | 0.370 |
Why?
|
| Animals | 22 | 2025 | 16992 | 0.360 |
Why?
|
| Bacillus megaterium | 1 | 2011 | 3 | 0.350 |
Why?
|
| Cattle Diseases | 1 | 2011 | 30 | 0.340 |
Why?
|
| Genetic Markers | 1 | 2011 | 150 | 0.330 |
Why?
|
| Flagella | 3 | 2025 | 32 | 0.330 |
Why?
|
| Genotype | 4 | 2015 | 800 | 0.320 |
Why?
|
| Shiga Toxin 2 | 2 | 2022 | 3 | 0.310 |
Why?
|
| Vibrio cholerae | 2 | 2025 | 105 | 0.310 |
Why?
|
| Humans | 25 | 2026 | 43102 | 0.300 |
Why?
|
| Shiga Toxin | 2 | 2022 | 5 | 0.280 |
Why?
|
| Wolinella | 2 | 2004 | 3 | 0.270 |
Why?
|
| Molecular Epidemiology | 4 | 2016 | 59 | 0.270 |
Why?
|
| Scarlet Fever | 1 | 2007 | 1 | 0.270 |
Why?
|
| Yersinia pseudotuberculosis Infections | 1 | 2007 | 3 | 0.270 |
Why?
|
| Yersinia pseudotuberculosis | 1 | 2007 | 7 | 0.270 |
Why?
|
| Cattle | 3 | 2022 | 498 | 0.270 |
Why?
|
| Genome, Fungal | 1 | 2007 | 28 | 0.270 |
Why?
|
| Helicobacter pylori | 2 | 2006 | 118 | 0.260 |
Why?
|
| Tigers | 1 | 2006 | 1 | 0.250 |
Why?
|
| Lions | 1 | 2006 | 2 | 0.250 |
Why?
|
| Acinonyx | 1 | 2006 | 2 | 0.250 |
Why?
|
| Helicobacter | 1 | 2006 | 3 | 0.250 |
Why?
|
| Fimbriae, Bacterial | 2 | 2025 | 30 | 0.250 |
Why?
|
| Fimbriae Proteins | 1 | 2025 | 25 | 0.240 |
Why?
|
| Water Microbiology | 2 | 2016 | 81 | 0.230 |
Why?
|
| Intestines | 1 | 2025 | 71 | 0.230 |
Why?
|
| Protein Kinases | 1 | 2025 | 100 | 0.230 |
Why?
|
| Species Specificity | 4 | 2012 | 286 | 0.220 |
Why?
|
| Helicobacter hepaticus | 1 | 2004 | 1 | 0.220 |
Why?
|
| Campylobacter jejuni | 1 | 2004 | 22 | 0.220 |
Why?
|
| Transcription, Genetic | 1 | 2025 | 592 | 0.190 |
Why?
|
| Sequence Analysis | 1 | 2022 | 26 | 0.190 |
Why?
|
| Evolution, Molecular | 3 | 2014 | 307 | 0.190 |
Why?
|
| Clone Cells | 1 | 2022 | 50 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2015 | 863 | 0.180 |
Why?
|
| Mice | 6 | 2025 | 6644 | 0.160 |
Why?
|
| Genomic Islands | 2 | 2011 | 16 | 0.160 |
Why?
|
| Genes, Bacterial | 3 | 2012 | 91 | 0.160 |
Why?
|
| Bacterial Adhesion | 2 | 2018 | 41 | 0.150 |
Why?
|
| Mutagenesis, Insertional | 2 | 2025 | 39 | 0.150 |
Why?
|
| Polymorphism, Genetic | 2 | 2011 | 201 | 0.150 |
Why?
|
| Military Personnel | 1 | 2020 | 110 | 0.150 |
Why?
|
| Dysentery, Bacillary | 1 | 2018 | 14 | 0.140 |
Why?
|
| Immunoglobulin A, Secretory | 1 | 2018 | 16 | 0.140 |
Why?
|
| Immunologic Factors | 1 | 2018 | 51 | 0.140 |
Why?
|
| Taurocholic Acid | 1 | 2017 | 5 | 0.140 |
Why?
|
| Amidohydrolases | 1 | 2017 | 12 | 0.140 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 71 | 0.130 |
Why?
|
| Neutrophils | 2 | 1995 | 145 | 0.130 |
Why?
|
| Haiti | 2 | 2014 | 86 | 0.130 |
Why?
|
| Databases, Genetic | 2 | 2014 | 103 | 0.130 |
Why?
|
| Meat | 2 | 2015 | 46 | 0.130 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2016 | 3 | 0.130 |
Why?
|
| Floods | 1 | 2016 | 6 | 0.130 |
Why?
|
| Enterotoxigenic Escherichia coli | 1 | 2016 | 5 | 0.130 |
Why?
|
| Rats | 5 | 2012 | 3735 | 0.120 |
Why?
|
| Ischemia | 1 | 1996 | 47 | 0.120 |
Why?
|
| Interleukin-10 | 1 | 1996 | 87 | 0.120 |
Why?
|
| Nasturtium | 1 | 2015 | 1 | 0.120 |
Why?
|
| Nepal | 1 | 2014 | 19 | 0.110 |
Why?
|
| Chromosomes, Bacterial | 2 | 2012 | 21 | 0.110 |
Why?
|
| Microbiology | 1 | 2014 | 2 | 0.110 |
Why?
|
| Genetics, Microbial | 1 | 2014 | 5 | 0.110 |
Why?
|
| Food-Processing Industry | 1 | 2014 | 2 | 0.110 |
Why?
|
| Anthrax | 1 | 2014 | 18 | 0.110 |
Why?
|
| Bacillus anthracis | 1 | 2014 | 33 | 0.110 |
Why?
|
| Base Sequence | 3 | 2012 | 983 | 0.100 |
Why?
|
| Food Supply | 1 | 2014 | 122 | 0.100 |
Why?
|
| Rats, Inbred Strains | 3 | 1997 | 126 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 1995 | 386 | 0.090 |
Why?
|
| Bacillus | 1 | 2012 | 12 | 0.090 |
Why?
|
| Conjugation, Genetic | 1 | 2012 | 14 | 0.090 |
Why?
|
| Prophages | 1 | 2011 | 4 | 0.090 |
Why?
|
| Capillary Permeability | 3 | 1996 | 36 | 0.090 |
Why?
|
| Arsenites | 1 | 2012 | 54 | 0.090 |
Why?
|
| Genetic Loci | 1 | 2011 | 104 | 0.090 |
Why?
|
| Incidence | 1 | 2014 | 1078 | 0.090 |
Why?
|
| Hospitalization | 1 | 2014 | 485 | 0.080 |
Why?
|
| Arsenic | 1 | 2012 | 155 | 0.080 |
Why?
|
| Guinea Pigs | 1 | 2010 | 143 | 0.080 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2009 | 7 | 0.080 |
Why?
|
| Disease Reservoirs | 1 | 2009 | 25 | 0.080 |
Why?
|
| Rodentia | 1 | 2009 | 47 | 0.080 |
Why?
|
| Phenotype | 1 | 2012 | 780 | 0.070 |
Why?
|
| China | 1 | 2009 | 229 | 0.070 |
Why?
|
| Antigens, Bacterial | 1 | 2010 | 144 | 0.070 |
Why?
|
| Chlamydia | 1 | 2009 | 45 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 694 | 0.070 |
Why?
|
| Superantigens | 1 | 2007 | 1 | 0.070 |
Why?
|
| Genes, Fungal | 1 | 2007 | 33 | 0.070 |
Why?
|
| Mycotoxins | 1 | 2007 | 12 | 0.070 |
Why?
|
| Chlamydia Infections | 1 | 2009 | 200 | 0.070 |
Why?
|
| Cell Membrane | 2 | 2006 | 403 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 1596 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2007 | 90 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2007 | 154 | 0.060 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2006 | 13 | 0.060 |
Why?
|
| Carbohydrates | 1 | 2006 | 32 | 0.060 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2006 | 57 | 0.060 |
Why?
|
| Superoxide Dismutase | 2 | 1997 | 158 | 0.060 |
Why?
|
| Acinetobacter Infections | 1 | 2025 | 29 | 0.060 |
Why?
|
| Flagellin | 1 | 2025 | 19 | 0.060 |
Why?
|
| Helicobacter Infections | 1 | 2006 | 86 | 0.060 |
Why?
|
| United States | 2 | 2014 | 5205 | 0.060 |
Why?
|
| Computational Biology | 2 | 2004 | 327 | 0.060 |
Why?
|
| Crystallography, X-Ray | 1 | 2025 | 280 | 0.060 |
Why?
|
| Bdellovibrio | 1 | 2004 | 10 | 0.050 |
Why?
|
| Genome | 2 | 2015 | 149 | 0.050 |
Why?
|
| Public Health | 1 | 2007 | 424 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2025 | 986 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 1869 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2015 | 455 | 0.050 |
Why?
|
| Aneurysm | 1 | 2001 | 5 | 0.040 |
Why?
|
| Endocarditis | 1 | 2001 | 11 | 0.040 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2001 | 26 | 0.040 |
Why?
|
| Heart Valve Prosthesis | 1 | 2001 | 44 | 0.040 |
Why?
|
| Aortic Valve | 1 | 2001 | 38 | 0.040 |
Why?
|
| Mutation | 1 | 2025 | 1177 | 0.040 |
Why?
|
| Kenya | 1 | 2020 | 58 | 0.040 |
Why?
|
| Travel | 1 | 2020 | 36 | 0.040 |
Why?
|
| Diarrhea | 1 | 2020 | 95 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2018 | 168 | 0.030 |
Why?
|
| Cecum | 1 | 2017 | 21 | 0.030 |
Why?
|
| Male | 5 | 2001 | 23409 | 0.030 |
Why?
|
| Sepsis | 1 | 2018 | 90 | 0.030 |
Why?
|
| Complement Activation | 1 | 1997 | 14 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 368 | 0.030 |
Why?
|
| Complement System Proteins | 1 | 1997 | 25 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1997 | 150 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2017 | 219 | 0.030 |
Why?
|
| Peroxidase | 1 | 1997 | 57 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2017 | 314 | 0.030 |
Why?
|
| Pakistan | 1 | 2016 | 20 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 457 | 0.030 |
Why?
|
| Macrophages, Alveolar | 1 | 1996 | 34 | 0.030 |
Why?
|
| Cholera Toxin | 1 | 2016 | 41 | 0.030 |
Why?
|
| Pulmonary Circulation | 1 | 1995 | 4 | 0.030 |
Why?
|
| Premedication | 1 | 1995 | 4 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 2015 | 16 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 245 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 1995 | 92 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 1996 | 259 | 0.030 |
Why?
|
| Animals, Domestic | 1 | 2015 | 11 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1995 | 127 | 0.030 |
Why?
|
| RNA | 1 | 1997 | 266 | 0.030 |
Why?
|
| Mexico | 1 | 2016 | 298 | 0.030 |
Why?
|
| Disease Vectors | 1 | 2014 | 11 | 0.030 |
Why?
|
| Reference Standards | 1 | 2014 | 55 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1996 | 384 | 0.030 |
Why?
|
| Georgia | 1 | 2014 | 192 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2017 | 876 | 0.030 |
Why?
|
| Communicable Diseases | 1 | 2014 | 47 | 0.030 |
Why?
|
| Open Reading Frames | 2 | 2004 | 79 | 0.030 |
Why?
|
| Cytokines | 1 | 1997 | 678 | 0.020 |
Why?
|
| Tandem Repeat Sequences | 1 | 2012 | 10 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 87 | 0.020 |
Why?
|
| Madagascar | 1 | 2011 | 9 | 0.020 |
Why?
|
| Minisatellite Repeats | 1 | 2011 | 18 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 207 | 0.020 |
Why?
|
| Time Factors | 1 | 1995 | 1857 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 575 | 0.020 |
Why?
|
| Phascolarctidae | 1 | 2009 | 1 | 0.020 |
Why?
|
| Chromosome Inversion | 1 | 2007 | 9 | 0.020 |
Why?
|
| Female | 2 | 2025 | 24698 | 0.020 |
Why?
|
| North America | 1 | 2007 | 85 | 0.020 |
Why?
|
| Base Pairing | 1 | 2007 | 41 | 0.020 |
Why?
|
| Hydrolases | 1 | 2004 | 15 | 0.010 |
Why?
|
| Peptidoglycan | 1 | 2004 | 12 | 0.010 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2004 | 24 | 0.010 |
Why?
|
| Gram-Negative Bacteria | 1 | 2004 | 29 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 97 | 0.010 |
Why?
|
| Biological Transport | 1 | 2004 | 204 | 0.010 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 100 | 0.010 |
Why?
|
| Glycosylation | 1 | 2003 | 113 | 0.010 |
Why?
|
| Amino Acids | 1 | 2004 | 148 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 206 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 2001 | 15 | 0.010 |
Why?
|
| Reoperation | 1 | 2001 | 34 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2001 | 263 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2001 | 1067 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2001 | 2544 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2003 | 2157 | 0.010 |
Why?
|
| Aged | 1 | 2001 | 8214 | 0.000 |
Why?
|
| Middle Aged | 1 | 2001 | 12222 | 0.000 |
Why?
|
| Adult | 1 | 2001 | 13872 | 0.000 |
Why?
|